Your browser doesn't support javascript.
loading
Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized, noninferiority trial.
Badell, Idelberto R; Parsons, Ronald F; Karadkhele, Geeta; Cristea, Octav; Mead, Sue; Thomas, Shine; Robertson, Jennifer M; Kim, Grace S; Hanfelt, John J; Pastan, Stephen O; Larsen, Christian P.
  • Badell IR; Emory Transplant Center, Atlanta, Georgia, USA.
  • Parsons RF; Emory Transplant Center, Atlanta, Georgia, USA.
  • Karadkhele G; Emory Transplant Center, Atlanta, Georgia, USA.
  • Cristea O; Emory Transplant Center, Atlanta, Georgia, USA.
  • Mead S; Emory Transplant Center, Atlanta, Georgia, USA.
  • Thomas S; Emory Transplant Center, Atlanta, Georgia, USA.
  • Robertson JM; Emory Transplant Center, Atlanta, Georgia, USA.
  • Kim GS; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Hanfelt JJ; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Pastan SO; Emory Transplant Center, Atlanta, Georgia, USA.
  • Larsen CP; Emory Transplant Center, Atlanta, Georgia, USA.
Am J Transplant ; 21(9): 3066-3076, 2021 09.
Article en En | MEDLINE | ID: mdl-33583120

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón Tipo de estudio: Clinical_trials / Etiology_studies / Guideline Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón Tipo de estudio: Clinical_trials / Etiology_studies / Guideline Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article